Webster, NY, United States of America

Kerinchan P Babaoglu

This inventor holds 1 USPTO granted patent. Top assignee: Johnson & Johnson Clinical Diagnostics, Inc.. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kerinchan P Babaoglu

Introduction

Kerinchan P Babaoglu is an accomplished inventor based in Webster, NY (US). He has made significant contributions to the field of clinical diagnostics, particularly through his innovative work at Johnson & Johnson Clinical Diagnostics, Inc. His expertise and dedication have led to the development of valuable medical technologies.

Latest Patents

Kerinchan holds a patent for an "Immunoassay kit for analysis of biological liquids." This invention is crucial for the accurate analysis of various biological samples, enhancing diagnostic capabilities in clinical settings. He has 1 patent to his name, showcasing his innovative contributions to the medical field.

Career Highlights

Throughout his career, Kerinchan has been associated with Johnson & Johnson Clinical Diagnostics, Inc., where he has played a pivotal role in advancing diagnostic technologies. His work has not only contributed to the company's success but has also had a positive impact on patient care and medical research.

Collaborations

Kerinchan has collaborated with notable colleagues, including Norbert S Norkus and Randall S Johnson. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge diagnostic solutions.

Conclusion

Kerinchan P Babaoglu's contributions to the field of clinical diagnostics exemplify the impact of innovation in healthcare. His work continues to influence the industry, paving the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…